Will the FDA approve Compass Pathways' COMP360 psilocybin? [ resolves 2028-01-01 (577D) ]

Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?

kalshi: [A] single source·objective outcome methodology ›

distribution · by resolution date

kalshi 5 markets

market	resolves	P(YES)	vol (24h)	vol (cum)	RCG	venue id
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression	2028-01-01	92.0%	—	$214	A	`KXFDAAPPROVA…N01`
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression	2028-01-01	77.0%	—	$1.6K	A	`KXFDAAPPROVA…T01`
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression	2028-01-01	75.0%	—	$5.3K	A	`KXFDAAPPROVA…L01`
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression…	2028-01-01	42.0%	—	$67	A	`KXFDAAPPROVA…R01`
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression…	2028-01-01	19.0%	—	$27	A	`KXFDAAPPROVA…N01`

resolution architecture

venue	proposer	source	citation	arbitration	class	analyst notes
kalshi	`Exchange Staff`	Food and Drug Administration	link	`Kalshi Staff`	`Other`	—

verbatim rules

kalshi 5 markets · share this text

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2027, then the market resolves to Yes.

platform source field kalshi.settlement_sources → "Food and Drug Administration" ↗

recent wire items

monitoring status: active no active wire

No CM Signal wire has been published for this event yet.

CM Signal’s news-cycle scan surfaces the day’s top stories alongside the prediction markets pricing them. When a story references this event, its wire is published here and links back to this page.

programmatic access · four surfaces, same payload

AI grounded search reads embedded JSON-LD in HTML. Developers query REST. Agentic AI clients (Claude Desktop, Cursor) call MCP tools. AI crawlers index via /llms.txt. Same canonical record at every surface.

HTML	browsers, AI grounded search, crawlers (embedded JSON-LD `@type: Dataset`)	`https://clearmarket.fyi/events/kxfdaapprovaldatecmps-360/`
JSON	REST API for developers	`https://api.clearmarket.fyi/v1/events/kxfdaapprovaldatecmps-360.json`
MCP	agentic AI tool call (Claude Desktop, Cursor, Continue)	`clearmarket.get_event("kxfdaapprovaldatecmps-360")`
AGENT	AI crawler discovery index	`/llms.txt`

 Snapshot 2026-06-03. Venue data via Kalshi + Polymarket APIs. Editorial fields (tags, editorial_notes) are ClearMarket-drafted with AI assistance under editorial review. Derived fields (venues_covered, resolution_clarity_grade, rcg_score) computed at serve time. Full per-field map in the JSON record under field_provenance.
  raw JSON record · same payload returned by REST endpoint
 {
  "event_id": "CM-EVT-QSB3J43MQ3",
  "slug": "kxfdaapprovaldatecmps-360",
  "question": "Will the FDA approve Compass Pathways' COMP360 psilocybin?",
  "category": "technology",
  "tags": [
    "technology",
    "psilocybin-therapy",
    "fda-approval",
    "mental-health-treatment",
    "biotech-regulation",
    "compass-pathways"
  ],
  "venues_covered": [
    "kalshi"
  ],
  "market_count": 5,
  "cumulative_volume_usd": 7254,
  "resolution_clarity_grade": "A",
  "rcg_score": 100,
  "rcg_caps": [],
  "resolution_source": "Food and Drug Administration",
  "resolution_source_url": "https://www.fda.gov/news-events/fda-newsroom/press-announcements",
  "arbitration_model": "kalshi_staff",
  "proposer_model": "platform_staff",
  "field_provenance": {
    "question": {
      "source": "clearmarket_editorial"
    },
    "tags": {
      "source": "clearmarket_editorial",
      "ai_drafted": true
    },
    "resolution_clarity_grade": {
      "source": "derived",
      "method": "rcg_v2_7factor"
    },
    "venues_covered": {
      "source": "derived"
    }
  }
}

snapshot 2026-06-03T14:52:43.794845+00:00 schema v0.2.0-universe all events →